-10.0%
EW vs MRNA
-8.0%
-2.0%
-54.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -3.6% | +3.6% | +0.1% |
| 7D | +2.3% | -20.0% | +22.3% | +3.2% |
| 30D | +23.7% | -1.3% | +24.9% | +23.6% |
| 3M | +16.9% | +240.0% | -223.0% | +7.6% |
| 6M | +31.6% | +339.0% | -307.4% | +17.8% |
| YTD | +25.6% | +630.0% | -604.3% | +6.6% |
| 1Y | +24.1% | +769.1% | -745.0% | +3.4% |
| 3Y | +58.8% | +181.2% | -122.5% | +40.9% |
| 5Y | -10.0% | -8.1% | -1.9% | -17.1% |
| All | -10.0% | -8.0% | -2.0% | -17.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling